According to Zhu et al. (Zhu et al., 2022), through m6A modification of HHLA2 mRNA, METTL3 regulates and promotes HHLA2 expression, thereby enabling RCC growth and invasion. Here, HHLA2 is linked to renal cell adenocarcinoma.